Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |